Healthcare provider profile · identity verified

Cassandra Lall, M.D.

Internal Medicine · BLOOMINGTON, MN · NPI 1770739732

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	686	199
Amlodipine Besylate	Amlodipine Besylate	634	195
Levothyroxine Sodium	Levothyroxine Sodium	525	131
Lisinopril	Lisinopril	512	148
Rosuvastatin Calcium	Rosuvastatin Calcium	415	125
Omeprazole	Omeprazole	365	112
Losartan Potassium	Losartan Potassium	306	94
Alendronate Sodium	Alendronate Sodium	253	83
Metoprolol Succinate	Metoprolol Succinate	201	59
Gabapentin	Gabapentin	188	77
Hydrochlorothiazide	Hydrochlorothiazide	174	52
Sertraline Hcl	Sertraline Hcl	167	54
Irbesartan	Irbesartan	154	45
Metformin Hcl Er	Metformin Hcl	142	41
Trazodone Hcl	Trazodone Hcl	134	34
Pravastatin Sodium	Pravastatin Sodium	130	42
Furosemide	Furosemide	123	40
Pantoprazole Sodium	Pantoprazole Sodium	120	38
Carvedilol	Carvedilol	118	37
Eliquis	Apixaban	118	39
Albuterol Sulfate Hfa	Albuterol Sulfate	116	47
Simvastatin	Simvastatin	113	35
Metformin Hcl	Metformin Hcl	110	34
Atenolol	Atenolol	108	34
Warfarin Sodium	Warfarin Sodium	105	33
Citalopram Hbr	Citalopram Hydrobromide	102	24
Potassium Chloride	Potassium Chloride	101	26
Tamsulosin Hcl	Tamsulosin Hcl	100	33
Fluticasone Propionate	Fluticasone Propionate	92	45
Metoprolol Tartrate	Metoprolol Tartrate	89	23
Bupropion Xl	Bupropion Hcl	79	25
Fluoxetine Hcl	Fluoxetine Hcl	78	25
Montelukast Sodium	Montelukast Sodium	74	23
Famotidine	Famotidine	66	22
Spironolactone	Spironolactone	63	19
Xarelto	Rivaroxaban	63	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	23
Escitalopram Oxalate	Escitalopram Oxalate	58	18
Meloxicam	Meloxicam	51	11
Zolpidem Tartrate	Zolpidem Tartrate	48	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	18
Glipizide Er	Glipizide	45	13
Hydroxyzine Hcl	Hydroxyzine Hcl	45	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	suppressed
Estradiol	Estradiol	42	16
Ipratropium Bromide	Ipratropium Bromide	42	12
Tramadol Hcl	Tramadol Hcl	41	18
Valacyclovir	Valacyclovir Hcl	40	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	11
Mirtazapine	Mirtazapine	33	suppressed
Clonidine Hcl	Clonidine Hcl	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	suppressed
Lorazepam	Lorazepam	32	suppressed
Methocarbamol	Methocarbamol	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Torsemide	Torsemide	31	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Celecoxib	Celecoxib	30	11
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Allopurinol	Allopurinol	29	11
Ibandronate Sodium	Ibandronate Sodium	28	11
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	11
Prednisone	Prednisone	28	24
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	11
Ventolin Hfa	Albuterol Sulfate	27	14
Klor-Con M20	Potassium Chloride	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Valsartan	Valsartan	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Ozempic	Semaglutide	25	suppressed
Risedronate Sodium	Risedronate Sodium	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Jantoven	Warfarin Sodium	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	16
Mometasone Furoate	Mometasone Furoate	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	19
Dulera	Mometasone/Formoterol	19	suppressed
Finasteride	Finasteride	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Baclofen	Baclofen	18	suppressed
Clotrimazole	Clotrimazole	18	13
Ketoconazole	Ketoconazole	18	suppressed
Ondansetron Odt	Ondansetron	18	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	16
Clonazepam	Clonazepam	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Nucynta	Tapentadol Hcl	16	suppressed
Ramipril	Ramipril	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	14
Diazepam	Diazepam	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Azithromycin	Azithromycin	13	13
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Glipizide	Glipizide	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Nystatin	Nystatin	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Clonidine	Clonidine	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Linzess	Linaclotide	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error